CNTB
NASDAQ · Biotechnology
Connect Biopharma Holdings L
$2.85
-0.05 (-1.72%)
Open$2.85
Previous Close$2.90
Day High$3.00
Day Low$2.78
52W High$3.74
52W Low$0.51
Volume—
Avg Volume235.3K
Market Cap206.28M
P/E Ratio—
EPS$-0.82
SectorBiotechnology
Analyst Ratings
Strong Buy
11 analysts
Price Target
+621.4% upside
Current
$2.85
$2.85
Target
$20.56
$20.56
$15.18
$20.56 avg
$23.56
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 35.24M | 69.44M | 70.73M |
| Net Income | -21,151,578 | 4.31M | 5.04M |
| Profit Margin | -60.0% | 6.2% | 7.1% |
| EBITDA | -25,987,293 | 5.85M | 6.49M |
| Free Cash Flow | — | 3.99M | 3.58M |
| Rev Growth | — | +2.8% | -4.7% |
| Debt/Equity | 0.00 | 0.90 | 0.87 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.98 | -1.15% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $353.28 | +0.41% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.30 | +0.67% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $447.26 | +0.16% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $777.25 | +0.60% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.73 | -0.65% | 139.7 | 43.84B |